Development and sales of Lonasen Tape (transdermal schizophrenia drug)
An individual pharmaceutical commercialization program for the transdermal schizophrenia drug Lonasen® Tape, covering its progression from formulation development through regulatory approval, commercial production and the start of domestic sales.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.